Skip to Content

Zofran

In the US, Zofran (ondansetron systemic) is a member of the drug class 5HT3 receptor antagonists and is used to treat Alcohol Dependence, Gastroenteritis, Nausea/Vomiting, Nausea/Vomiting - Chemotherapy Induced, Nausea/Vomiting - Postoperative, Nausea/Vomiting - Radiation Induced, Obsessive Compulsive Disorder, Postanesthetic Shivering and Pruritus.

US matches:

UK matches:

Ingredient matches for Zofran

Ondansetron

Ondansetron is reported as an ingredient of Zofran in the following countries:

  • Belgium
  • China
  • Czech Republic
  • Egypt
  • Hungary
  • Ireland
  • Italy
  • Japan
  • Lebanon
  • Malta
  • Netherlands
  • Peru
  • Philippines
  • Poland
  • United Kingdom

Ondansetron hydrochloride dihydrate (a derivative of Ondansetron) is reported as an ingredient of Zofran in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Brazil
  • Bulgaria
  • Canada
  • Croatia (Hrvatska)
  • Czech Republic
  • Estonia
  • Finland
  • Georgia
  • Germany
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Latvia
  • Lithuania
  • Malaysia
  • Netherlands
  • New Zealand
  • Norway
  • Oman
  • Portugal
  • Serbia
  • Singapore
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • Turkey
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide